168 related articles for article (PubMed ID: 15008503)
1. Early modifications of auditory event-related potentials in carriers of the Huntington's disease gene.
de Tommaso M; Sciruicchio V; Specchio N; Difruscolo O; Vitale C; Specchio LM; Puca F
Acta Neurol Belg; 2003 Dec; 103(4):192-8. PubMed ID: 15008503
[TBL] [Abstract][Full Text] [Related]
2. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.
Foroud T; Siemers E; Kleindorfer D; Bill DJ; Hodes ME; Norton JA; Conneally PM; Christian JC
Ann Neurol; 1995 May; 37(5):657-64. PubMed ID: 7755361
[TBL] [Abstract][Full Text] [Related]
3. Interpeak latency of auditory event-related potentials (P300) in senile depression and dementia of the Alzheimer type.
Sumi N; Nan'no H; Fujimoto O; Ohta Y; Takeda M
Psychiatry Clin Neurosci; 2000 Dec; 54(6):679-84. PubMed ID: 11145468
[TBL] [Abstract][Full Text] [Related]
4. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
Robins Wahlin TB; Lundin A; Dear K
Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
[TBL] [Abstract][Full Text] [Related]
5. Visual function in Huntington's disease patients and presymptomatic gene carriers.
O'Donnell BF; Wilt MA; Hake AM; Stout JC; Kirkwood SC; Foroud T
Mov Disord; 2003 Sep; 18(9):1027-34. PubMed ID: 14502670
[TBL] [Abstract][Full Text] [Related]
6. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.
Wolf RC; Vasic N; Schönfeldt-Lecuona C; Landwehrmeyer GB; Ecker D
Brain; 2007 Nov; 130(Pt 11):2845-57. PubMed ID: 17855375
[TBL] [Abstract][Full Text] [Related]
7. Stimulus-response compatibility in Huntington's disease: a cognitive-neurophysiological analysis.
Beste C; Saft C; Andrich J; Gold R; Falkenstein M
J Neurophysiol; 2008 Mar; 99(3):1213-23. PubMed ID: 18184888
[TBL] [Abstract][Full Text] [Related]
8. Assessment of simple movements reflects impairment in Huntington's disease.
Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
[TBL] [Abstract][Full Text] [Related]
9. Huntington's disease: neurological assessment of potential gene carriers presenting for predictive DNA testing.
McCusker E; Richards F; Sillence D; Wilson M; Trent RJ
J Clin Neurosci; 2000 Jan; 7(1):38-41. PubMed ID: 10847649
[TBL] [Abstract][Full Text] [Related]
10. Response inhibition in Huntington's disease-a study using ERPs and sLORETA.
Beste C; Saft C; Andrich J; Gold R; Falkenstein M
Neuropsychologia; 2008 Apr; 46(5):1290-7. PubMed ID: 18241897
[TBL] [Abstract][Full Text] [Related]
11. [Event-related potentials in progressive supranuclear palsy].
Sato K; Takeuchi H; Kamoda M; Touge T; Yamada A; Nishioka M
Rinsho Shinkeigaku; 1993 Apr; 33(4):382-8. PubMed ID: 8370199
[TBL] [Abstract][Full Text] [Related]
12. Event-related potentials in panic disorder and generalized anxiety disorder.
Hanatani T; Sumi N; Taguchi S; Fujimoto O; Nan-No H; Takeda M
Psychiatry Clin Neurosci; 2005 Feb; 59(1):83-8. PubMed ID: 15679545
[TBL] [Abstract][Full Text] [Related]
13. Saccades in presymptomatic and early stages of Huntington disease.
Blekher T; Johnson SA; Marshall J; White K; Hui S; Weaver M; Gray J; Yee R; Stout JC; Beristain X; Wojcieszek J; Foroud T
Neurology; 2006 Aug; 67(3):394-9. PubMed ID: 16855205
[TBL] [Abstract][Full Text] [Related]
14. Assessment of complex movements reflects dysfunction in Huntington's disease.
Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
J Neurol; 2003 Dec; 250(12):1469-74. PubMed ID: 14673581
[TBL] [Abstract][Full Text] [Related]
15. Cognitive dysfunction in NIDDM: P3 event related evoked potential study.
Tandon OP; Verma A; Ram BK
Indian J Physiol Pharmacol; 1999 Jul; 43(3):383-8. PubMed ID: 10776489
[TBL] [Abstract][Full Text] [Related]
16. Nociceptive inputs transmission in Huntington's disease: a study by laser evoked potentials.
De Tommaso M; Serpino C; Difruscolo O; Cormio C; Sciruicchio V; Franco G; Farella I; Livrea P
Acta Neurol Belg; 2011 Mar; 111(1):33-40. PubMed ID: 21510231
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives.
Soliveri P; Monza D; Piacentini S; Paridi D; Nespolo C; Gellera C; Mariotti C; Albanese A; Girotti F
Neurol Sci; 2002 Sep; 23 Suppl 2():S105-6. PubMed ID: 12548365
[TBL] [Abstract][Full Text] [Related]
18. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment.
Kingma EM; van Duijn E; Timman R; van der Mast RC; Roos RA
Gen Hosp Psychiatry; 2008; 30(2):155-61. PubMed ID: 18291297
[TBL] [Abstract][Full Text] [Related]
19. Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentials.
Beste C; Konrad C; Saft C; Ukas T; Andrich J; Pfleiderer B; Hausmann M; Falkenstein M
Exp Neurol; 2009 Mar; 216(1):148-57. PubMed ID: 19111540
[TBL] [Abstract][Full Text] [Related]
20. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.
Marshall J; White K; Weaver M; Flury Wetherill L; Hui S; Stout JC; Johnson SA; Beristain X; Gray J; Wojcieszek J; Foroud T
Arch Neurol; 2007 Jan; 64(1):116-21. PubMed ID: 17210818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
